首页/数据集/Fact Sheet for Healthcare Providers Emergency Use Authorization (EUA) of Sotrovimab

Fact Sheet for Healthcare Providers Emergency Use Authorization (EUA) of Sotrovimab

NCATS Open Data2021-05-27 更新2026-08-08 收录

COVID-19单克隆抗体治疗

药物紧急使用授权

数据链接：

https://www.fda.gov/media/149534/download 数据链接链接失效反馈

官方服务：

资源简介：

Fact Sheet for Healthcare Providers Emergency Use Authorization (EUA) of Sotrovimab

应用场景：

创建时间：

2021-05-27

药物紧急使用授权

Bebtelovimab临床指导

Fact Sheet for Healthcare Providers: Emergency Use Authorization for Bebtelovimab

NCATS Open Data2022-02-18 更新10

Emergency Use Authorization (EUA) for Pemivibart (PEMGARDA) Center for Drug Evaluation and Research (CDER) Review

药物紧急使用授权

监管审查

Emergency Use Authorization (EUA) for Pemivibart (PEMGARDA) Center for Drug Evaluation and Research (CDER) Review

NCATS Open Data2024-04-26 更新00

Dataset from A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients With COVID-19

COVID-19单克隆抗体治疗

药物临床试验

Phase 1* To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo* To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SAR

NIAID Data Ecosystem00

Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Bamlanivimab and Etesevimab (05/20/2021)

COVID-19单克隆抗体治疗

紧急使用授权监管

Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Bamlanivimab and Etesevimab (05/20/2021)

NCATS Open Data2021-06-04 更新00

Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir

COVID-19治疗

药物紧急使用授权

Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir

NCATS Open Data2022-03-04 更新00

Fact Sheet for Healthcare Providers Emergency Use Authorization (EUA) of Sotrovimab

资源简介：

相关数据集